Zero to Hero? Scope 3 Emissions – A Strategic Imperative for Pharma Companies Verena Ahnert Read more
Executive Insights Life Sciences & Pharma Trends In Neuroscience Drug Discovery And Development November 7, 2025
Video / Webinar Life Sciences & Pharma Navigating China's Volume-Based Procurement in the Pharma Industry August 27, 2025
Video / Webinar Life Sciences & Pharma Unlocking China's Precision Medicine Potential August 25, 2025
Executive Insights Healthcare Services A View Into the Promise of Continuous Manufacturing June 30, 2025
Executive Insights Life Sciences & Pharma From Bench to Bedside: Academic-to-Industry Translation in European Biopharma June 25, 2025